Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy

被引：130
|
作者：
Thibodeau, Jacques [1 ]
Bourgeois-Daigneault, Marie-Claude [1 ]
Lapointe, Rejean [2 ,3 ]
机构：
[1] Univ Montreal, Dept Microbiol & Immunol, Lab Immunol Mol, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Notre Dame Hosp, CRCHUM, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Inst Canc Montreal, Montreal, PQ H2L 4M1, Canada
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 06期
基金：
加拿大健康研究院;
关键词：
cancer; HLA; immunotherapy; MHC Class II; tumor; vaccine; CD4(+) T-CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; INVARIANT CHAIN; HLA-DR; TUMOR-CELLS; METASTATIC MELANOMA; IMMUNE-RESPONSE; B-CELLS; EXPRESSION; CIITA;
D O I：
10.4161/onci.21205
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The success of immunotherapy relies on the participation of all arms of the immune system and the role of CD4(+) T lymphocytes in preventing tumor growth is now well established. Understanding how tumors evade immune responses holds the key to the development of cancer immunotherapies. In this review, we discuss how MHC Class II expression varies in cancer cells and how this influences antitumor immune responses. We also discuss the means that are currently available for harnessing the MHC Class II antigen presentation pathway for the development of efficient vaccines to activate the immune system against cancer.
引用
收藏
页码：908 / 916
页数：9
相关论文
共 50 条
  • [21] CLASS-II MHC MOLECULES CAN USE THE ENDOGENOUS PATHWAY OF ANTIGEN PRESENTATION
    NUCHTERN, JG
    BIDDISON, WE
    KLAUSNER, RD
    NATURE, 1990, 343 (6253) : 74 - 76
  • [22] Design of a ProDer f 1 vaccine delivered by the MHC class II pathway of antigen presentation and analysis of the effectiveness for specific immunotherapy
    Liu, Zhiming
    Jiang, Yuxin
    Li, Chaopin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (08): : 4636 - 4644
  • [23] Actin microfilaments control the MHC class II antigen presentation pathway in B cells
    Barois, N
    Forquet, F
    Davoust, J
    JOURNAL OF CELL SCIENCE, 1998, 111 : 1791 - 1800
  • [24] Antigen presentation by MHC class I and II molecules
    Neefjes, JJ
    IMMUNOBIOLOGY, 1996, 195 (4-5) : 456 - 460
  • [25] Viral inhibition of MHC class II antigen presentation
    Hegde, NR
    Chevalier, MS
    Johnson, DC
    TRENDS IN IMMUNOLOGY, 2003, 24 (05) : 278 - 285
  • [26] Influence of Salmonella on MHC class II antigen presentation
    Jackson, N.
    Kang, Y. H.
    Lapaque, N.
    Janssen, H.
    Trowsdale, J.
    Kelly, A. P.
    IMMUNOLOGY, 2012, 137 : 478 - 478
  • [27] Proteases involved in MHC class II antigen presentation
    Villadangos, JA
    Bryant, RAR
    Deussing, J
    Driessen, C
    Lennon-Duménil, AM
    Riese, RJ
    Roth, W
    Saftig, P
    Shi, GP
    Chapman, HA
    Peters, C
    Ploegh, HL
    IMMUNOLOGICAL REVIEWS, 1999, 172 : 109 - 120
  • [28] Routes to manipulate MHC class II antigen presentation
    van den Hoorn, Tineke
    Paul, Petra
    Jongsma, Marlieke L. M.
    Neefjes, Jacques
    CURRENT OPINION IN IMMUNOLOGY, 2011, 23 (01) : 88 - 95
  • [29] Proteolysis and antigen presentation by MHC class II molecules
    Bryant, PW
    Lennon-Duménil, AM
    Fiebiger, E
    Lagaudrière-Gesbert, C
    Ploegh, HL
    ADVANCES IN IMMUNOLOGY, VOL 80, 2002, 80 : 71 - 114
  • [30] Components of the cytoplasmic antigen processing pathway regulates indirect antigen presentation by MHC class II molecules
    Joyce, Sebastian
    Dragovic, Srdjan
    Hill, Timothy
    Christianson, Gregory
    Roopenian, Derry
    Van Kaer, Luc
    JOURNAL OF IMMUNOLOGY, 2012, 188
12345